Azacitidine
Azacitidine
Definition
A pyrimidine nucleoside analogue of cytidine with antineoplastic activity. Azacitidine is incorporated into DNA, where it reversibly inhibits DNA methyltransferase, thereby blocking DNA methylation. Hypomethylation of DNA by azacitidine may activate tumor suppressor genes silenced by hypermethylation, resulting in an antitumor effect. This agent is also incorporated into RNA, thereby disrupting normal RNA function and impairing tRNA cytosine-5-methyltransferase activity. (NCI04)
Also known as 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazin-2(1H)-one, 5 AZC, 5-AC, 5-Aza-cytidine, 5-Azacitidine, 5-Azacytidine, 5-AZC, AZACITIDINE, Azacytidine, Azacytidine, 5-, Ladakamycin, Mylosar, U-18496, Vidaza — per NCIT
Also identified as
- ATC L01BC07 per RXNORM
- NCIT NCIT:C288 per NCIT
- SCTID 412328000 per RXNORM
- SCTID 412329008 per RXNORM
- UNII M801H13NRU per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Chronic myelomonocytic leukemia | may treat | MEDRT · Public domain (U.S. Government work) |
| Myelodysplastic syndrome with single lineage dysplasia | may treat | MEDRT · Public domain (U.S. Government work) |
| Sideroblastic anemia | may treat | MEDRT · Public domain (U.S. Government work) |
Organ Effects
| Organ | Side effect / interaction | Source |
|---|---|---|
| Bone marrow | may treat a disease of this organ | DERIVED · CC BY 4.0 |
1 entry above is marked DERIVED: Atlas Médico inferred it by combining two sourced claims, and no source asserts this link directly. Treat it as a navigation aid, not as a clinical statement.